Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
Bibliographic Data
| ID | 15364385 |
|---|---|
| Authors | D Riethmuller (0000-0002-5718-6112, Hôpital Saint-Jacques, corresponding author), Anne‐Carole Jacquard (Sanofi (France)), Anne-Carole Jacquard, Jean Lacau St Guily (Sorbonne Université), F Aubin (0000-0002-1421-4996, Centre Hospitalier Universitaire de Besançon), Xavier Carcopino (0000-0002-9533-3558, Centre National de la Recherche Scientifique), Pierre Pradat (0000-0001-6331-8321, Hôpital de la Croix-Rousse), André Dahlab (Sanofi (France)), Jean‐Luc Prétet (0000-0002-8430-214X, Centre Hospitalier Universitaire de Besançon), Jean-Luc Prétet |
| Year | 2015 |
| Volume | 15 |
| Issue | 1 |
| Pages | 453-453 |
| Publication date | 2015-05-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | BMC Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1471-2458 • E-ISSN: 1471-2458 |
| Publisher | BioMed Central (PUBLISHER • GB) |
| DOI | 10.1186/s12889-015-1779-1 |
| PMID | 25934423 |
| PMCID | PMC4433025 |
| OpenAlex | W1995688817 |
| Language | EN |
| Citations received | 1 |
| References cited | 21 |
The nonavalent HPV vaccine showed significant increased potential impact compared to the HPV 6/11/16/18 quadrivalent vaccine for ICC, CIN2/3 and LSIL. Considering a 100% vaccine efficacy and high vaccine coverage, about 90% of ICC, CIN2/3, GW or anal cancer cases could be prevented by a nonavalent HPV vaccine in France
Anal cancer · Cancer · Cervical cancer · Genital warts · Genotype · Gynecology · HPV infection · HPV vaccines · Human papillomavirus · Cervical Cancer and HPV Research · Colorectal and Anal Carcinomas · Head and Neck Cancer Studies · Medicine · Epidemiology · Internal Medicine · Oncology
| Citations per year | 0.17 |
|---|---|
| Citation span | 2020 - 2020 (1) |
| Highly cited | No |